March 16 (Reuters) – Catalent Inc plans to expand its COVID-19 vaccine production in Europe that will enable it to make more doses of Johnson & Johnson’s shot, the Wall Street Journal reported https://www.wsj.com/articles/catalent-to-expand-production-of-j-j-covid-19-vaccine-in-italy-11615941463?mod=latest_headlines on Tuesday, citing people familiar with the matter.

The contract drug manufacturer will bring online a second J&J vaccine production line at its plant in Anagni, Italy, during the fourth quarter, the Journal reported. (Reporting by Aakriti Bhalla in Bengaluru; editing by Uttaresh.V)

Our Standards: The Thomson Reuters Trust Principles.

Source:
https://news.trust.org/item/20210317000046-tovmk

Similar articles:

Leave a Reply

Your email address will not be published. Required fields are marked *